Skip to main content
. 2021 Jan 8;12:3. doi: 10.4103/jpi.jpi_72_20

Table 5.

Subspecialties and distribution of individual parts by diagnostic category

Subspecialty Diagnostic category Total parts
HN Negative for malignancy 22
Reactive lymphoid tissue 2
Inflammation including granulomatous type 15
Benign 5
Dysplasia 10
Atypical squamous proliferation 8
Suspicious for carcinoma 6
Carcinoma 138
Malignancy/metastasis 11
Necrosis only/inadequate/nonrepresentative biopsy 3
BR Negative for malignancy 3
Inflammation 3
Benign 9
DCIS 1
Invasive breast carcinoma 53
Malignancy/metastasis 21
Necrosis 1
GI Negative for malignancy 6
Inflammation including granulomatous type 4
Benign 3
Suspicious for adenocarcinoma 1
Malignancy/ metastasis 101
Inadequate 1
GY Benign 3
CIN/CIS 2
Suspicious for metastasis 1
Metastasis 19
Carcinoma 25
Inflammation 3
BST Granuloma 1
Sarcoma 3
Metastasis 5
Plasma cell neoplasm 2
TH Negative for malignancy 3
Reactive 1
Granuloma 5
Carcinoma 37
Malignancy/metastasis 31
GU Negative for malignancy 11
Necrosis 1
Inflammation 2
Carcinoma 25
Atypical small acinar proliferation 1
Germ cell tumor 1
Benign 6

HN: Head and neck, BR: Breast, GI: Gastrointestinal, TH: Thoracic pathology, BST: Bone and soft tissue, GY: Gynepathology, GU: Genitourinary, DCIS: Ductal carcinoma in-situ, CIN/CIS: Cervical intraepithelial neoplasia/Carcinoma in-situ